Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Biotech Medics Ne

Healthcare US BMCS

0.0001USD
-0.0002(66.67%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00110.01
LowHigh

Fundamentals

  • Previous Close 0.0003
  • Market Cap0.23M
  • Volume21001
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.03M
  • Revenue TTM0.47M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM 0.41M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.00292M -0.00562M -0.11515M -0.32256M -0.10967M
Minority interest - - - - -
Net income -0.00292M -0.00562M -0.11515M -0.32256M -0.10967M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation - - - - -
Ebit - 0.02M -0.34364M -0.32256M -0.10967M
Ebitda -0.00292M 0.19M -0.11515M -0.08600M 0.10M
Depreciation and amortization - 0.17M 0.23M 0.24M 0.21M
Non operating income net other - - - - -
Operating income -0.00292M -0.00469M -0.11515M -0.32256M -0.15423M
Other operating expenses 0.00292M 0.03M 0.12M 0.32M 0.15M
Interest expense - - - - -
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.16789M -0.22848M -0.23656M -0.20630M
Total revenue - - - - -
Total operating expenses 0.00292M 0.03M 0.12M 0.32M 0.15M
Cost of revenue - - - - -
Total other income expense net - 0.02M 0.00000M - 0.04M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 100.00M 100.00M 70.00M 70.00M 0.00038M
Intangible assets 0.02M 0.02M 0.02M 0.02M -
Earning assets - - - - -
Other current assets - - - - -
Total liab 0.44M 0.43M 0.43M 0.33M 0.19M
Total stockholder equity 99.57M 99.57M 69.58M 69.67M -0.18678M
Deferred long term liab - - - - -
Other current liab 0.40M 0.37M 0.43M 0.33M 0.19M
Common stock 0.21M 0.20M 0.20M 0.20M 0.20M
Capital stock - - - - -
Retained earnings -1.71574M -1.65773M -1.65211M -1.53696M -1.21440M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.00000M 0.00010M - -0.00073M 0.00001M
Cash and equivalents - - - - -
Total current liabilities 0.44M 0.43M 0.43M 0.33M 0.19M
Current deferred revenue - - - - -
Net debt 0.00200M 0.03M - 0.00073M -0.00001M
Short term debt 0.00200M 0.03M - - -
Short long term debt - - - - -
Short long term debt total 0.00200M 0.03M - - -
Other stockholder equity 101.07M 101.22M -0.20236M -0.20236M -0.20236M
Property plant equipment - - - - -
Total current assets 0.00000M 0.00010M - -0.00073M 0.00001M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.04M 0.04M - - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.20236M 71.23M 71.21M 1.03M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.02M - - -
Deferred long term asset charges - - - - -
Non current assets total 100.00M 100.00M 70.00M 70.00M 0.00037M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -30.00000M - -70.00200M -0.00037M -
Net borrowings - - - - -
Total cash from financing activities 30.03M 0.02M 70.18M 0.03M -
Change to operating activities - - - - -
Net income -0.00562M -0.11515M -0.32256M -0.10967M -0.06140M
Change in cash 0.00010M 0.00145M -0.00073M 0.00001M -
Begin period cash flow 0.00073M -0.00073M 0.00001M - -
End period cash flow 0.00010M 0.00073M -0.00073M 0.00001M -
Total cash from operating activities -0.02690M -0.01677M -0.18203M -0.02962M -
Issuance of capital stock - - - - -
Depreciation - - - - -
Other cashflows from investing activities 0.00000M - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities -30.00000M 0.02M -70.00200M 0.03M -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00200M 0.00037M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.02127M 0.10M 0.14M 0.12M 0.06M
Stock based compensation - - - - -
Other non cash items -0.02364M - - -0.04456M -
Free cash flow -0.02690M -0.01677M -0.18404M -0.02999M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
BMCS
Biotech Medics Ne		 -0.0002 66.67% 0.0001 - - 0.48 -
ZTS
Zoetis Inc		 -2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Biotech Medics Ne

PO Box 93476, Southlake, TX, United States, 76092-0114

Key Executives

Name Title Year Born
Mr. Keith A. Houser Chairman & Interim Pres 1949
Anthony Keith Miller Chief Exec. Officer NA
Mr. James C. Nairne Chief Financial Officer NA
Mr. Tom Wood Sr. VP of Sales NA
Mr. Keith A. Houser Chairman & Interim President 1949
Anthony Keith Miller Chief Executive Officer NA
Mr. Tom Wood Senior Vice President of Sales NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions